Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Herbs and fungi can potentially treat hair loss effectively with fewer side effects.

Oral and topical finasteride are effective and safe for treating female hair loss.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The document concludes that signs of male and female pattern baldness include uneven hair thickness, yellow spots, skin discoloration around hair follicles, more thin and soft hairs, and many hair follicles with just one hair.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Various treatments exist for hair loss, but more research is needed for better options.

Moderately high prolactin levels do not cause hair loss in women.

Monofilament Threads significantly improve hair growth in women with pattern hair loss and are safe.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.